- Home
- VRDN vs AVDX Comparison
VRDN vs AVDX Comparison
Compare VRDN & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- AVDX
- Stock Information
- Founded
- VRDN 2006
- AVDX 2000
- Country
- VRDN United States
- AVDX United States
- Employees
- VRDN N/A
- AVDX N/A
- Industry
- VRDN Medical Specialities
- AVDX EDP Services
- Sector
- VRDN Health Care
- AVDX Technology
- Exchange
- VRDN Nasdaq
- AVDX Nasdaq
- Market Cap
- VRDN 1.6B
- AVDX 1.6B
- IPO Year
- VRDN N/A
- AVDX 2021
- Fundamental
- Price
- VRDN $13.48
- AVDX $8.48
- Analyst Decision
- VRDN Buy
- AVDX Hold
- Analyst Count
- VRDN 12
- AVDX 15
- Target Price
- VRDN $36.44
- AVDX $9.79
- AVG Volume (30 Days)
- VRDN 766.3K
- AVDX 2.2M
- Earning Date
- VRDN 05-07-2025
- AVDX 05-07-2025
- Dividend Yield
- VRDN N/A
- AVDX N/A
- EPS Growth
- VRDN N/A
- AVDX N/A
- EPS
- VRDN N/A
- AVDX 0.04
- Revenue
- VRDN $302,000.00
- AVDX $438,940,000.00
- Revenue This Year
- VRDN N/A
- AVDX $6.41
- Revenue Next Year
- VRDN $17,629.40
- AVDX $10.70
- P/E Ratio
- VRDN N/A
- AVDX $215.71
- Revenue Growth
- VRDN N/A
- AVDX 15.29
- 52 Week Low
- VRDN $11.40
- AVDX $6.61
- 52 Week High
- VRDN $27.20
- AVDX $13.27
- Technical
- Relative Strength Index (RSI)
- VRDN 32.50
- AVDX 51.15
- Support Level
- VRDN $14.03
- AVDX $8.15
- Resistance Level
- VRDN $15.91
- AVDX $8.78
- Average True Range (ATR)
- VRDN 0.67
- AVDX 0.38
- MACD
- VRDN -0.10
- AVDX 0.14
- Stochastic Oscillator
- VRDN 6.51
- AVDX 86.21
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.